Pharmacovigilance of antiretroviral dolutegravir in the state of Paraná
The aim of this study was to investigate adverse reactions to Dolutegravir, a drug recently made available by the Unified Health System (SUS) for treating HIV infections. The frequency, severity and sex distribution of adverse reactions to Dolutegravir were identified over the first 18 months of it...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Universidade Estadual de Maringá
2022-01-01
|
Series: | Acta Scientiarum. Health Sciences |
Subjects: | |
Online Access: | https://periodicos.uem.br/ojs/index.php/ActaSciHealthSci/article/view/53630 |